Draft Guidance for Industry, Clinical Investigators, Institutional Review Boards, and Staff; Availability: Decisions for Investigational Device Exemption Clinical Investigations
Title: The Procter & Gamble Company - Docket FDA-2011-D-0790_P&G Comments-9Mar2012
The Procter & Gamble Company - Comment
This is comment on Notice
Draft Guidance for Industry, Clinical Investigators, Institutional Review Boards, and Staff; Availability: Decisions for Investigational Device Exemption Clinical Investigations
View Comment
Attachments:
The Procter & Gamble Company - Docket FDA-2011-D-0790_P&G Comments-9Mar2012
Title:
The Procter & Gamble Company - Docket FDA-2011-D-0790_P&G Comments-9Mar2012
Related Comments
View AllPublic Submission Posted: 02/28/2012 ID: FDA-2011-D-0790-0005
Mar 09,2012 11:59 PM ET
Public Submission Posted: 02/28/2012 ID: FDA-2011-D-0790-0006
Mar 09,2012 11:59 PM ET
Public Submission Posted: 03/14/2012 ID: FDA-2011-D-0790-0007
Mar 09,2012 11:59 PM ET
Public Submission Posted: 03/14/2012 ID: FDA-2011-D-0790-0008
Mar 09,2012 11:59 PM ET
Public Submission Posted: 03/14/2012 ID: FDA-2011-D-0790-0011
Mar 09,2012 11:59 PM ET